
Venkataraman Balasubramanian
Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )
Most Active Art Unit | 1624 |
Art Unit(s) | 1624, 1611 |
Total Applications | 2999 |
Issued Applications | 2017 |
Pending Applications | 254 |
Abandoned Applications | 728 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9739853
[patent_doc_number] => 20140275572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/214864
[patent_app_country] => US
[patent_app_date] => 2014-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13604
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14214864
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/214864 | SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF | Mar 14, 2014 | Abandoned |
Array
(
[id] => 10685786
[patent_doc_number] => 20160031930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/775678
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44747
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775678
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/775678 | NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF | Mar 12, 2014 | Abandoned |
Array
(
[id] => 10649268
[patent_doc_number] => 09365502
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-14
[patent_title] => 'Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors'
[patent_app_type] => utility
[patent_app_number] => 14/200219
[patent_app_country] => US
[patent_app_date] => 2014-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 4
[patent_no_of_words] => 28722
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14200219
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/200219 | Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors | Mar 6, 2014 | Issued |
Array
(
[id] => 10663611
[patent_doc_number] => 20160009755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'CYRRHETINIC ALKYL ESTERS AND PROTECTED DERIVATIVES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/771687
[patent_app_country] => US
[patent_app_date] => 2014-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3973
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14771687
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/771687 | CYRRHETINIC ALKYL ESTERS AND PROTECTED DERIVATIVES THEREOF | Feb 27, 2014 | Abandoned |
Array
(
[id] => 11210828
[patent_doc_number] => 09439845
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-13
[patent_title] => 'Glycyrrhetinimidyl hydroxyproline alkyl esters and protected derivatives thereof'
[patent_app_type] => utility
[patent_app_number] => 14/771384
[patent_app_country] => US
[patent_app_date] => 2014-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4395
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14771384
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/771384 | Glycyrrhetinimidyl hydroxyproline alkyl esters and protected derivatives thereof | Feb 27, 2014 | Issued |
Array
(
[id] => 9699435
[patent_doc_number] => 20140249120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-04
[patent_title] => 'NEUROACTIVE 13, 17-SUBSTITUTED STEROIDS AS MODULATORS FOR GABA TYPE-A RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 14/191740
[patent_app_country] => US
[patent_app_date] => 2014-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25318
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14191740
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/191740 | Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors | Feb 26, 2014 | Issued |
Array
(
[id] => 10522682
[patent_doc_number] => 09249180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-02
[patent_title] => 'C-3 alkyl and alkenyl modified betulinic acid derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/186533
[patent_app_country] => US
[patent_app_date] => 2014-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37138
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14186533
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/186533 | C-3 alkyl and alkenyl modified betulinic acid derivatives | Feb 20, 2014 | Issued |
Array
(
[id] => 11809706
[patent_doc_number] => 09714266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-25
[patent_title] => 'Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (AKR1C3)'
[patent_app_type] => utility
[patent_app_number] => 14/770444
[patent_app_country] => US
[patent_app_date] => 2014-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25415
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14770444
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/770444 | Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (AKR1C3) | Feb 17, 2014 | Issued |
Array
(
[id] => 11054429
[patent_doc_number] => 20160251391
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2016-09-01
[patent_title] => 'NEUROACTIVE ENANTIOMERIC 15-, 16- AND 17-SUBSTITUTED STEROIDS AS MODULATORS FOR GABA TYPE-A RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 14/767235
[patent_app_country] => US
[patent_app_date] => 2014-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 34372
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14767235
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/767235 | Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors | Feb 13, 2014 | Issued |
Array
(
[id] => 11054429
[patent_doc_number] => 20160251391
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2016-09-01
[patent_title] => 'NEUROACTIVE ENANTIOMERIC 15-, 16- AND 17-SUBSTITUTED STEROIDS AS MODULATORS FOR GABA TYPE-A RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 14/767235
[patent_app_country] => US
[patent_app_date] => 2014-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 34372
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14767235
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/767235 | Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors | Feb 13, 2014 | Issued |
Array
(
[id] => 10220361
[patent_doc_number] => 20150105355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => '4-DEDIMETHYLAMINO TETRACYCLINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/176923
[patent_app_country] => US
[patent_app_date] => 2014-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28145
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14176923
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/176923 | 4-dedimethylamino tetracycline compounds | Feb 9, 2014 | Issued |
Array
(
[id] => 10693720
[patent_doc_number] => 20160039866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => '16- AND 17- DEUTERATED ESTROGEN-3-SULFAMATES AS ESTROGENIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/767175
[patent_app_country] => US
[patent_app_date] => 2014-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6018
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14767175
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/767175 | 16- AND 17- DEUTERATED ESTROGEN-3-SULFAMATES AS ESTROGENIC AGENTS | Feb 9, 2014 | Abandoned |
Array
(
[id] => 9643249
[patent_doc_number] => 20140221361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'C-19 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/172389
[patent_app_country] => US
[patent_app_date] => 2014-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89606
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14172389
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/172389 | C-19 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | Feb 3, 2014 | Abandoned |
Array
(
[id] => 9511919
[patent_doc_number] => 20140148412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-29
[patent_title] => 'NOVEL 17B-HETEROARYL-SUBSTITUTED STEROIDS AS MODULATORS OF GABAA RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 14/166912
[patent_app_country] => US
[patent_app_date] => 2014-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13125
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14166912
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/166912 | NOVEL 17B-HETEROARYL-SUBSTITUTED STEROIDS AS MODULATORS OF GABAA RECEPTORS | Jan 28, 2014 | Abandoned |
Array
(
[id] => 10663608
[patent_doc_number] => 20160009752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'PREGNANE-OXIMINO-AMINOALKYLETHERS AND PROCESS FOR PREPARATION THEREOF, USEFUL AS ANTIDIABETIC AND ANTIDYSLIPIDEMIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/763480
[patent_app_country] => US
[patent_app_date] => 2014-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12466
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14763480
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/763480 | PREGNANE-OXIMINO-AMINOALKYLETHERS AND PROCESS FOR PREPARATION THEREOF, USEFUL AS ANTIDIABETIC AND ANTIDYSLIPIDEMIC AGENTS | Jan 23, 2014 | Abandoned |
Array
(
[id] => 10422416
[patent_doc_number] => 20150307426
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2015-10-29
[patent_title] => 'INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/162136
[patent_app_country] => US
[patent_app_date] => 2014-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60014
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14162136
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/162136 | INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS | Jan 22, 2014 | Abandoned |
Array
(
[id] => 10422416
[patent_doc_number] => 20150307426
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2015-10-29
[patent_title] => 'INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/162136
[patent_app_country] => US
[patent_app_date] => 2014-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60014
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14162136
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/162136 | INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS | Jan 22, 2014 | Abandoned |
Array
(
[id] => 9616801
[patent_doc_number] => 20140206657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'BILE ACID ANALOG TGR5 AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 14/159995
[patent_app_country] => US
[patent_app_date] => 2014-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 32672
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14159995
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/159995 | BILE ACID ANALOG TGR5 AGONISTS | Jan 20, 2014 | Abandoned |
Array
(
[id] => 10451990
[patent_doc_number] => 20150337004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'NOVEL BETULINIC ACID PROLINE DERIVATIVES AS HIV INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/758309
[patent_app_country] => US
[patent_app_date] => 2013-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56090
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14758309
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/758309 | Betulinic acid proline derivatives as HIV inhibitors | Dec 25, 2013 | Issued |
Array
(
[id] => 10459503
[patent_doc_number] => 20150344518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'ESTROGEN RECEPTOR IMAGING AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/649702
[patent_app_country] => US
[patent_app_date] => 2013-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 11190
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14649702
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/649702 | Estrogen receptor imaging agents | Dec 9, 2013 | Issued |